January 31st, 2014
Abbott Can't Escape FCA Suit Over Drug Marketing, Kickbacks
By Kelly Knaub
A Pennsylvania federal judge refused Thursday to dismiss a former Abbott Laboratories employee’s suit claiming the company submitted false claims to government health programs by pushing its cholesterol drug TriCor for off-label uses and paying kickbacks to physicians.
In a 50-page memorandum, U.S. District Judge C. Darnell Jones II said that relator Amy Bergman “provides myriad details of Abbott’s marketing statements that contradict its FDA-approved label,” rejecting Abbott’s argument that the allegations of its False Claims Act violations are not specific enough to proceed.